HIV-1 Tat and heparan sulfate proteoglycan interaction: A novel mechanism of lymphocyte adhesion and migration across the endothelium

Blood

Volumn 114, Issue 15, 2009, Pages 3335-3342

  Urbinati, Chiara ^a   Nicoli, Stefania ^a   Giacca, Mauro ^b   David, Guido ^c   Fiorentini, Simona ^d   Caruso, Arnaldo ^d   Alfano, Massimo ^e   Cassetta, Luca ^e   Presta, Marco ^a   Rusnati, Marco ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d School of Medicine   (Italy)

^e SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; HEPARIN LYASE; HOMODIMER; INTEGRIN; PROTEOHEPARAN SULFATE; RANTES; STROMAL CELL DERIVED FACTOR 1; SYNDECAN 1; TRANSACTIVATOR PROTEIN; CCL5 PROTEIN, HUMAN; CXCL12 PROTEIN, HUMAN; SDC1 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL SURFACE; CELL TYPE; COMEELX FORMATION; COMPLEX FORMATION; CONTROLLED STUDY; DIMERIZATION; DNA TRANSFECTION; DONOR; EMBRYO; ENDOTHELIUM; ENDOTHELIUM CELL; EXTRAVASATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; LYMPHOCYTE; LYMPHOCYTE MIGRATION; LYMPHOID CELL; LYMPHOID TISSUE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING; ZEBRA FISH; ANIMAL; ANIMAL EMBRYO; CATTLE; CELL MOTION; GENETIC TRANSFECTION; GENETICS; METABOLISM; PROTEIN MULTIMERIZATION; TUMOR CELL LINE; VASCULAR ENDOTHELIUM;

ANIMALS; CATTLE; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINE CCL5; CHEMOKINE CXCL12; EMBRYO, NONMAMMALIAN; ENDOTHELIUM, VASCULAR; HEPARAN SULFATE PROTEOGLYCANS; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTES; PROTEIN MULTIMERIZATION; SYNDECAN-1; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRANSFECTION; ZEBRAFISH;

EID: 70350464619     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-01-198945     Document Type: Article

References (50)

1. Noonan D, Albini A. From the outside in: extracellular activities of HIV Tat. Adv Pharmacol. 2000;48:229-250.
2. Westendorp MO, Frank R, Ochsenbauer C, et al. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature. 1995;375:497-500.
3. Marchio S, Alfano M, Primo L, et al. Cell surface-associated Tat modulates HIV-1 infection and spreading through a specific interaction with gp120 viral envelope protein. Blood. 2005;105:2802-2811. (Pubitemid 40446273)
4. Chang HC, Samaniego F, Nair BC, Buonaguro L, Ensoli B. HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. AIDS. 1997;11:1421-1431. (Pubitemid 27421173)
5. Rusnati M, Presta M. HIV-1 Tat protein and endothelium: from protein/cell interaction to AIDS-associated pathologies. Angiogenesis. 2002;5:141-151. (Pubitemid 36687517)
6. Barillari G, Gendelman R, Gallo RC, Ensoli B. The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc Natl Acad Sci U S A. 1993;90:7941-7945. (Pubitemid 23260830)
7. Vogel BE, Lee SJ, Hildebrand A, et al. A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin. J Cell Biol. 1993;121:461-468. (Pubitemid 23110888)
8. Toborek M, Lee YW, Pu H, et al. HIV-Tat protein induces oxidative and inflammatory pathways in brain endothelium. J Neurochem. 2003;84:169-179. (Pubitemid 36182077)
9. Toschi E, Barillari G, Sgadari C, et al. Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor. Mol Biol Cell. 2001;12:2934-2946. (Pubitemid 33062952)
10. Colombrino E, Rossi E, Ballon G, et al. Human immunodeficiency virus type 1 Tat protein modulates cell cycle and apoptosis in Epstein-Barr virus-immortalized B cells. Exp Cell Res. 2004;295:539-548. (Pubitemid 38490505)
11. Huang L, Li CJ, Pardee AB. Human immunodeficiency virus type 1 TAT protein activates B lymphocytes. Biochem Biophys Res Commun. 1997;237:461-464. (Pubitemid 27406053)
12. Kundu RK, Sangiorgi F, Wu LY, et al. Expression of the human immunodeficiency virus-Tat gene in lymphoid tissues of transgenic mice is associated with B-cell lymphoma. Blood. 1999;94:275-282. (Pubitemid 29300159)
13. Levine AM. Acquired immunodeficiency syndrome-related lymphoma. Blood. 1992;80:8-20.
14. Lindahl U, Lidholt K, Spillmann D, Kjellen L. More to "heparin" than anticoagulation. Thromb Res. 1994;75:1-32.
15. Gotte M. Syndecans in inflammation. FASEB J. 2003;17:575-591.
16. Sanderson RD, Borset M. Syndecan-1 in B lymphoid malignancies. Ann Hematol. 2002;81:125-135.
17. Jones KS, Petrow-Sadowski C, Bertolette DC, Huang Y, Ruscetti FW. Heparan sulfate proteoglycans mediate attachment and entry of human Tcell leukemia virus type 1 virions into CD4+ T cells. J Virol. 2005;79:12692-12702. (Pubitemid 41433189)
18. Teixe T, Nieto-Blanco P, Vilella R, Engel P, Reina M, Espel E. Syndecan-2 and -4 expressed on activated primary human CD4+ lymphocytes can regulate T cell activation. Mol Immunol. 2008;45:2905-2919.
19. Ohshiro Y, Murakami T, Matsuda K, Nishioka K, Yoshida K, Yamamoto N. Role of cell surface glycosaminoglycans of human T cells in human immunodeficiency virus type-1 (HIV-1) infection. Microbiol Immunol. 1996;40:827-835. (Pubitemid 27034133)
20. Carbone A, Gloghini A, Larocca LM, et al. Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas. Blood. 2001;97:744-751. (Pubitemid 32113409)
21. Rusnati M, Presta M. Extracellular angiogenic growth factor interactions: an angiogenesis interactome survey. Endothelium. 2006;13:93-111. (Pubitemid 44173111)
22. Rusnati M, Tulipano G, Urbinati C, et al. The basic domain in HIV-1 Tat protein as a target for polysulfonated heparin-mimicking extracellular Tat antagonists. J Biol Chem. 1998;273:16027-16037. (Pubitemid 28311370)
23. Fittipaldi A, Ferrari A, Zoppe M, et al. Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins. J Biol Chem. 2003;278:34141-34149. (Pubitemid 37553255)
24. Tyagi M, Rusnati M, Presta M, Giacca M. Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J Biol Chem. 2001;276:3254-3261. (Pubitemid 37411619)
25. Urbinati C, Bugatti A, Giacca M, Schlaepfer D, Presta M, Rusnati M. alpha (v) beta3-integrin-dependent activation of focal adhesion kinase mediates NF-kappaB activation and motogenic activity by HIV-1 Tat in endothelial cells. J Cell Sci. 2005;118:3949-3958. (Pubitemid 41410278)
26. Zhang Z, Coomans C, David G. Membrane heparan sulfate proteoglycan-supported FGF2-FGFR1 signaling: evidence in support of the "cooperative end structures" model. J Biol Chem. 2001;276:41921-41929.
27. Grinspan JB, Mueller SN, Levine EM. Bovine endothelial cells transformed in vitro by benzo (a) pyrene. J Cell Physiol. 1983;114:328-338.
28. Alessandri G, Chirivi RG, Castellani P, Nicolo G, Giavazzi R, Zardi L. Isolation and characterization of human tumor-derived capillary endothelial cells: role of oncofetal fibronectin. Lab Invest. 1998;78:127-128. (Pubitemid 28074316)
29. Poli G, Orenstein JM, Kinter A, Folks TM, Fauci AS. Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines. Science. 1989;244:575-577. (Pubitemid 19140811)
30. Rusnati M, Tanghetti E, Dell'Era P, Gualandris A, Presta M. alphavbeta3 integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF-2) in cultured endothelial cells. Mol Biol Cell. 1997;8:2449-2461. (Pubitemid 27528213)
31. Cross LM, Cook MA, Lin S, Chen JN, Rubinstein AL. Rapid analysis of angiogenesis drugs in a live fluorescent zebrafish assay. Arterioscler Thromb Vasc Biol. 2003;23:911-912. (Pubitemid 36566186)
32. Westerfield M. The Zebrafish Book. Eugene, OR: University of Oregon Press; 1995.
33. Traver D, Paw BH, Poss KD, Penberthy WT, Lin S, Zon LI. Transplantation and in vivo imaging of multilineage engraftment in zebrafish bloodless mutants. Nat Immunol. 2003;4:1238-1246. (Pubitemid 37540693)
34. Soehnlein O, Xie X, Ulbrich H, et al. Neutrophil-derived heparin-binding protein (HBP/CAP37) deposited on endothelium enhances monocyte arrest under flow conditions. J Immunol. 2005;174:6399-6405. (Pubitemid 40663833)
35. Rusnati M, Urbinati C, Presta M. Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: role of the low affinity heparin-like bFGF receptors. J Cell Physiol. 1993;154:152-161. (Pubitemid 23024006)
36. Battaglia PA, Longo F, Ciotta C, Del Grosso MF, Ambrosini E, Gigliani F. Genetic tests to reveal TAT homodimer formation and select TAT homodimer inhibitor. Biochem Biophys Res Commun. 1994;201:701-708. (Pubitemid 24206928)
37. Tosi G, Meazza R, De Lerma Barbaro A, et al. Highly stable oligomerization forms of HIV-1 Tat detected by monoclonal antibodies and requirement of monomeric forms for the transactivating function on the HIV-1 LTR. Eur J Immunol. 2000;30:1120-1126. (Pubitemid 30216229)
38. Rosen SD. Ligands for L-selectin: homing, inflammation, and beyond. Annu Rev Immunol. 2004;22:129-156.
39. Chirivi RG, Taraboletti G, Bani MR, et al. Human immunodeficiency virus-1 (HIV-1)-Tat protein promotes migration of acquired immunodeficiency syndrome-related lymphoma cells and enhances their adhesion to endothelial cells. Blood. 1999;94:1747-1754. (Pubitemid 29411325)
40. Tanaka Y. Activation of leukocyte function-associated antigen-1 on adult T-cell leukemia cells. Leuk Lymphoma. 1999;36:15-23. (Pubitemid 30011624)
41. Bertolini F, Dell'Agnola C, Mancuso P, et al. CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma. Cancer Res. 2002;62:3106-3112. (Pubitemid 34602402)
42. Renshaw SA, Loynes CA, Trushell DM, Elworthy S, Ingham PW, Whyte MK. A transgenic zebrafish model of neutrophilic inflammation. Blood. 2006;108:3976-3978. (Pubitemid 44913264)
43. Nicoli S, Ribatti D, Cotelli F, Presta M. Mammalian tumor xenografts induce neovascularization in zebrafish embryos. Cancer Res. 2007;67:2927-2931. (Pubitemid 46724826)
44. Urbinati C, Mitola S, Tanghetti E, et al. Integrin alphavbeta3 as a target for blocking HIV-1 Tat-induced endothelial cell activation in vitro and angiogenesis in vivo. Arterioscler Thromb Vasc Biol. 2005;25:2315-2320. (Pubitemid 41552648)
45. Frankel AD, Chen L, Cotter RJ, Pabo CO. Dimerization of the tat protein from human immunodeficiency virus: a cysteine-rich peptide mimics the normal metal-linked dimer interface. Proc Natl Acad Sci U S A. 1988;85:6297-6300. (Pubitemid 18219155)
46. Weeks BS. The role of HIV-1 activated leukocyte adhesion mechanisms and matrix metalloproteinase secretion in AIDS pathogenesis [review]. Int J Mol Med. 1998;1:361-366.
47. Arese M, Ferrandi C, Primo L, Camussi G, Bussolino F. HIV-1 Tat protein stimulates in vivo vascular permeability and lymphomononuclear cell recruitment. J Immunol. 2001;166:1380-1388. (Pubitemid 32060301)
48. Dhawan S, Puri RK, Kumar A, Duplan H, Masson JM, Aggarwal BB. Human immunodeficiency virus-1-tat protein induces the cell surface expression of endothelial leukocyte adhesion molecule-1, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in human endothelial cells. Blood. 1997;90:1535-1544. (Pubitemid 27355425)
49. Chen JJ, Huang JC, Shirtliff M, et al. CD4 lymphocytes in the blood of HIV(+) individuals migrate rapidly to lymph nodes and bone marrow: support for homing theory of CD4 cell depletion. J Leukoc Biol. 2002;72:271-278.
50. Bugatti A, Urbinati C, Ravelli C, De Clercq E, Liekens S, Rusnati M. Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of human immunodeficiency virus type 1 Tat and gp120 proteins. Antimicrob Agents Chemother. 2007;51:2337-2345. (Pubitemid 47047308)